A novel hybrid convolutional and recurrent neural network model for automatic pituitary adenoma classification using dynamic contrast-enhanced MRI.

Authors

Motamed M,Bastam M,Tabatabaie SM,Elhaie M,Shahbazi-Gahrouei D

Affiliations (4)

  • Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Department of Computer Engineering, University of Mazandaran, Babolsar, Iran.
  • Department of Radiology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
  • Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. [email protected].

Abstract

Pituitary adenomas, ranging from subtle microadenomas to mass-effect macroadenomas, pose diagnostic challenges for radiologists due to increasing scan volumes and the complexity of dynamic contrast-enhanced MRI interpretation. A hybrid CNN-LSTM model was trained and validated on a multi-center dataset of 2,163 samples from Tehran and Babolsar, Iran. Transfer learning and preprocessing techniques (e.g., Wiener filters) were utilized to improve classification performance for microadenomas (< 10 mm) and macroadenomas (> 10 mm). The model achieved 90.5% accuracy, an area under the receiver operating characteristic curve (AUROC) of 0.92, and 89.6% sensitivity (93.5% for microadenomas, 88.3% for macroadenomas), outperforming standard CNNs by 5-18% across metrics. With a processing time of 0.17 s per scan, the model demonstrated robustness to variations in imaging conditions, including scanner differences and contrast variations, excelling in real-time detection and differentiation of adenoma subtypes. This dual-path approach, the first to synergize spatial and temporal MRI features for pituitary diagnostics, offers high precision and efficiency. Supported by comparisons with existing models, it provides a scalable, reproducible tool to improve patient outcomes, with potential adaptability to broader neuroimaging challenges.

Topics

Journal Article

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.